TY - JOUR
T1 - Lessons learned while developing "Clinical Trials Education for Native Americans" curriculum.
AU - Burhansstipanov, Linda
AU - Krebs, Linda U.
AU - Bradley, Alice
AU - Gamito, Eduard
AU - Osborn, Kyle
AU - Dignan, Mark B.
AU - Kaur, Judith S.
PY - 2003
Y1 - 2003
N2 - This paper highlights lessons learned while developing the Clinical Trials Education for Native Americans (CTENA) curriculum. The CTENA is a culturally specific clinical trials education curriculum that evolved from another ongoing NCI-supported project, Clinical Trials Education for Colorado Providers. The multicultural team learned many lessons while developing, pretesting, and revising this curriculum. These include allocating sufficient time and resources to tailor presentations for diverse tribal settings and workshop participants, addressing barriers to participation in clinical trials through culturally appropriate strategies, providing information to foster informed decision making related to participation, and writing as a team to increase cultural breadth of examples and interactive experiences. There are multiple challenges to developing and implementing a culturally acceptable curriculum on clinical trials within medically underserved communities. Both the multicultural team and the curriculum benefited from the collaborative process, resulting in a culturally relevant clinical trials curriculum that will assist Native Americans to make informed choices about clinical trials participation. The lessons shared here, which may need to be modified to be culturally relevant to other underrepresented communities, may be beneficial to others developing similar curricula for other medically underserved populations.
AB - This paper highlights lessons learned while developing the Clinical Trials Education for Native Americans (CTENA) curriculum. The CTENA is a culturally specific clinical trials education curriculum that evolved from another ongoing NCI-supported project, Clinical Trials Education for Colorado Providers. The multicultural team learned many lessons while developing, pretesting, and revising this curriculum. These include allocating sufficient time and resources to tailor presentations for diverse tribal settings and workshop participants, addressing barriers to participation in clinical trials through culturally appropriate strategies, providing information to foster informed decision making related to participation, and writing as a team to increase cultural breadth of examples and interactive experiences. There are multiple challenges to developing and implementing a culturally acceptable curriculum on clinical trials within medically underserved communities. Both the multicultural team and the curriculum benefited from the collaborative process, resulting in a culturally relevant clinical trials curriculum that will assist Native Americans to make informed choices about clinical trials participation. The lessons shared here, which may need to be modified to be culturally relevant to other underrepresented communities, may be beneficial to others developing similar curricula for other medically underserved populations.
UR - http://www.scopus.com/inward/record.url?scp=3142748606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3142748606&partnerID=8YFLogxK
U2 - 10.1177/107327480301005s05
DO - 10.1177/107327480301005s05
M3 - Article
C2 - 14581902
AN - SCOPUS:3142748606
SN - 1073-2748
VL - 10
SP - 29
EP - 36
JO - Cancer Control
JF - Cancer Control
IS - 5 Suppl
ER -